Equitec Proprietary Markets, LLC / 430
Equitec Proprietary Markets, LLC’s Terns Pharmaceuticals Inc Position
Does Equitec Proprietary Markets, LLC own Terns Pharmaceuticals Inc (430)? Yes — 100.5K shares worth $5M (+2.83% of its 13F portfolio) as of Q1 2026.
Position Value
$5M
Q1 2026
Shares
100.5K
% of Portfolio
+2.83%
Quarters Held
1
currently held
Position History 430
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 100.5K | $5M | +2.83% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Equitec Proprietary Markets, LLC’s full portfolio or all institutional holders of 430.